Protease Assay Using Cleavage-Generated Neo-Binding Sites

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for detecting enzymatic activities, such as protease activity, are limited in sensitivity and specificity, particularly for factors like FXa, FVIII, and caspase enzymes, which are crucial for coagulation pathways and disease diagnosis.

Innovation Solution

The method involves combining a sample with a substrate that contains an amino acid sequence with a cleavage site for the protease, where cleavage generates a neo-binding-site, and using a binding molecule that preferentially binds the neo-binding-site after protease activity, allowing for enhanced detection of protease activity through binding detection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If chromogenic substrates are used for detecting protease activity, then the detection method is simple and widely applicable, but the sensitivity and specificity are limited

Engineering Contradiction:
Improvesensitivity and specificity of protease activity detectionVSAvoidcomplexity of detection method
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The substrate is divided into two functional parts: a protease recognition sequence (e.g., IEGR for FXa) and a heterologous neo-binding-site sequence (e.g., FLAG, HA, or V5 epitopes). This segmentation allows the substrate to serve dual purposes: being recognized by the protease and generating a detectable neo-binding-site upon cleavage, thereby improving sensitivity and specificity without requiring complex detection systems

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

A binding molecule (such as an antibody or affinity reagent) is introduced as an intermediary to detect the neo-binding-site generated by protease cleavage. This intermediary provides enhanced detection capability through specific binding interactions, allowing for more sensitive and specific measurement of protease activity compared to direct chromogenic detection

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If conventional chromogenic substrates are used, then the assay procedure is straightforward, but the ability to accurately measure low levels of protease activity is insufficient

Engineering Contradiction:
Improvedetection accuracy of low protease activity levelsVSAvoidsimplicity of assay procedure
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The invention utilizes colorimetric detection through chromogenic substrates that change color upon protease-mediated cleavage. The substrate contains a chromophore (such as pNA) that releases a colored product when cleaved, providing a visual and measurable signal that enhances detection accuracy for low levels of protease activity while maintaining procedural simplicity

Inventive Principle:
Principle #32Color changes

3Measurement precision

If a substrate with a heterologous neo-binding-site is used, then sensitivity and specificity improve, but the substrate design and synthesis become more complex

Engineering Contradiction:
Improvespecificity of protease detectionVSAvoidsubstrate design and synthesis complexity
Core Design Contradiction:
Measurement precisionVSEase of manufacture

Solution Approach 1:

The substrate design incorporates universal, well-characterized neo-binding-site sequences (such as FLAG, HA, V5, or Myc epitopes) that can be recognized by commercially available binding molecules. This multi-functionality approach allows the same substrate structure to be used for detecting various proteases by simply changing the protease recognition sequence, thereby reducing long-term manufacturing and detection complexity

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach improves the sensitivity and specificity of protease activity detection, enabling accurate measurement of FXa, FVIII, and caspase activities, which is essential for coagulation factor analysis and disease diagnosis.

Implementation Method 1

cleavage at the cleavage site generates a neo-binding-site

Methodology Applied
Scientific EffectEnzymatic hydrolysis: Hydrolysis

Implementation Method 2

the first binding molecule preferentially binds the neo-binding-site after cleavage of the substrate by the protease activity

Methodology Applied
Scientific EffectMolecular binding: Adsorption

Data Source

PatentUS9244073B2Assays for detecting enzymatic activity
Publication Date: 2016.01.26 PHARMA CINQ LLC
  • US9244073B2 patent drawing
  • US9244073B2 patent drawing
  • US9244073B2 patent drawing

AI summary

The present invention relates to method of detecting activity of a sample. Some methods involve detecting a neo-binding-site created by the activity such as detecting an activity of a protease by detecting a neo-binding-site created by cleavage of a substrate by the protease.